Home / CLINICIANS / Clinical Evidence / PAD I
USA / International
pad i 1

Impressive Results, Excellent Safety in CE Mark Study

Single-arm, Pre-Market European study demonstrating the safety and performance of IVL as standalone therapy in heavily calcified, fem-pop lesions and followed to 6 months.

DISRUPT PAD I

By The Numbers

35
35 Patients followed out to 6 months
98%
98% severely calcified lesions by PARC
80
80mm average calcified length

Compelling Safety & Performance

in Severely Calcified Lesions*
100%
Procedural Success
0%
Perforations, Embolization, Slow/No Reflow, Abrupt Closure
23%
Final residual Stenosis with an acute gain of 2.9mm
82.1%
Patency
100%
Freedom From Clinical Driven TLR
*Core Lab & CEC adjudicated
Full Study Results

Ready to Make Waves with Shockwave Medical?

Looking for careers? Click here.